Citation Impact
Citing Papers
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Hypoxia-Inducible Factors in Physiology and Medicine
2012 StandoutNobel
Platelet Glycoprotein IIb/IIIa Receptors in Cardiovascular Medicine
1995
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials
2003 Standout
A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines?
2008
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Outcomes of elderly patients with cardiogenic shock treated with early percutaneous revascularization
2004
Universal Definition of Myocardial Infarction
2007 Standout
Dynamic prognostication in non-ST–elevation acute coronary syndromes: insights from GUSTO-IIB and pursuit
2004
Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1
2007 StandoutNobel
Randomized Comparison of Primary Coronary Angioplasty With Thrombolytic Therapy in Low Risk Patients With Acute Myocardial Infarction
1997
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Analysis of Case-Cohort Designs
1999
The Electrocardiographic Exercise Test in a Population with Reduced Workup Bias: Diagnostic Performance, Computerized Interpretation, and Multivariable Prediction
1998
Comparison of the prognostic value of C-Reactive protein and troponin I in patients with unstable angina pectoris
1998
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
2007
Limitations of Sensitivity, Specificity, Likelihood Ratio, and Bayesʼ Theorem in Assessing Diagnostic Probabilities
1997
Exercise Standards for Testing and Training
2013 Standout
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials
1999
C-reactive protein: a critical update
2003 Standout
Antiplatelet Effects of MK‐852, a Platelet Fibrinogen Receptor Antagonist, in Healthy Volunteers
2000
Early eicosapentaenoic acid treatment after percutaneous coronary intervention reduces acute inflammatory responses and ventricular arrhythmias in patients with acute myocardial infarction: A randomized, controlled study
2014
ACC/AHA 2002 Guideline Update for Exercise Testing: Summary Article
2002 Standout
Early exercise testing after acute myocardial infarction in the elderly: Clinical evaluation and prognostic significance
1993
Heart Rate adjustment of ST segment depression and performance of the exercise electrocardiogram: A critical evaluation
1995
High Sensitivity C-reactive Protein: An Emerging Role in Cardiovascular Risk Assessment
2002
Role of thrombosis in atherosclerosis and its complications
1995
Association of Fibrinogen, C-reactive Protein, Albumin, or Leukocyte Count With Coronary Heart Disease
1998 Standout
The importance of selenium to human health
2000 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Comparison of Treatment and Outcome of Acute Coronary Syndrome in Patients With Versus Patients Without Diabetes Mellitus
2009
Fish Intake, Contaminants, and Human Health
2006 Standout
Elevated C-Reactive Protein Levels in Overweight and Obese Adults
1999 Standout
Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention
2001
Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy
2000
Management of acute myocardial infarction in patients presenting with ST-segment elevation
2003
Myocardial Reperfusion Injury
2007 Standout
Revisiting Reperfusion Therapy in Inferior Myocardial Infarction
1997
Third Universal Definition of Myocardial Infarction
2012 Standout
Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial
1996
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease?
2009
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
The significance of lead strength on ST changes during treadmill stress tests
1992
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Shock in acute myocardial infarction: the Cape Horn for trials?
2010
The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary
2008
EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection
2016 StandoutNobel
Usefulness of high-sensitivity C-Reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction
2002
Evaluation of left ventricular structure and function by three-dimensional echocardiography
2013
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion
2011
Inhibition of Platelet Glycoprotein IIb/IIIa with Eptifibatide in Patients with Acute Coronary Syndromes
1998 Standout
Patterned Hydrogels for Controlled Platelet Adhesion from Whole Blood and Plasma
2010 StandoutNobel
Open Multicentre Study of the P 2T Receptor Antagonist AR-C69931MX Assessing Safety, Tolerability and Activity in Patients with Acute Coronary Syndromes
2001
Cardiogenic Shock
2008
Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention
2001
Preservation of global and regional left ventricular function after early thrombolysis in acute myocardial infarction
1986
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Clinical Outcomes of Therapeutic Agents That Block the Platelet Glycoprotein IIb/IIIa Integrin in Ischemic Heart Disease
1998
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
Thrombolytic therapy in patients with acute myocardial infarction.
1985
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.
1987 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Effect of ST segment measurement point on performance of standard and heart rate-adjusted ST segment criteria for the identification of coronary artery disease.
1991
Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
1998
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
2010
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Exercise Standards for Testing and Training
2001
Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial
2001
Attainment and Maintenance of Platelet Inhibition Through Standard Dosing of Abciximab in Diabetic and Nondiabetic Patients Undergoing Percutaneous Coronary Intervention
1999
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
2018 Standout
Electrochemiluminescence (ECL)
2004 Standout
Platelet Glycoprotein IIb/IIIa Receptor Blockade and Low-Dose Heparin during Percutaneous Coronary Revascularization
1997 Standout
Gender-Specific Criteria and Performance of the Exercise Electrocardiogram
1995
Acute Profound Thrombocytopenia After c7E3 Fab (Abciximab) Therapy
1997
Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness
2007 Standout
Anti-GPIIb/IIIa Drugs: Current Strategies and Future Directions
2001
Physical Activity and Public Health in Older Adults
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
2000 Standout
Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation
2000
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
1985
The Mononuclear Molybdenum Enzymes
2014 Standout
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
2012 Standout
Impact of Prior Use or Recent Withdrawal of Oral Antiplatelet Agents on Acute Coronary Syndromes
2004
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 Standout
Nitric oxide prevents axonal degeneration by inducing HIF-1–dependent expression of erythropoietin
2011 StandoutNobel
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Heart Rate Adjustment of Exercise-Induced ST-Segment Depression Identifies Men Who Benefit From a Risk Factor Reduction Program
1997
Hypoxia-inducible factor 1 is required for remote ischemic preconditioning of the heart
2013 StandoutNobel
Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study
1999
Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
2012 StandoutNobel
Comparison of ST segment/heart rate index to standard ST criteria for analysis of exercise electrocardiogram.
1990
Works of M. L. Simoons being referenced
Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart
2006
Immediate angioplasty: a conservative view from Europe.
1995
Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase
1997
Estimated gain in life expectancy: A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction
1996
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI–SK study
2002
Rapid and accurate measurement of LV mass by biplane real-time 3D echocardiography in patients with concentric LV hypertrophy: Comparison to CMR☆
2007
Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies
2007
Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk
1995
Prior aspirin use predicts worse outcomes in patients with non–ST-elevation acute coronary syndromes11This study was sponsored by COR Therapeutics Inc., South San Francisco, California; and Schering-Plough Research Institute, Kenilworth, New Jersey.
1999
Platelet glycoprotein IIb/IIIa blockade and outcome of cardiogenic shock complicating acute coronary syndromes without persistent ST-segment elevation
2000
Coronary recanalization in acute myocardial infarction: immediate results and potential risks
1982
Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction: the AMI-SK study
2003
A comparison of methods of analysing exercise tests for diagnosis of coronary artery disease.
1989
Tailored thrombolytic therapy. A perspective.
1993
Predischarge stress test after myocardial infarction in the old age: Results and prognostic value
1984
Well shaped ST segment and risk of cardiovascular mortality.
1992
Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.
1994
Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival
1987